ABOUT ACCELLTA

About Us

About Us

Why Accellta ?Cost - 50 fold manufacturing cost savingTime - 3 fold manufacturing time reductionQuality - Exceptional cell quality

Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing for custom-made process development, clinical and R&D applications. Our novel technology offers carrier free suspension culture for PSCs. Accellta's technologies are the result of over 20 years of pioneering research and development at the Stem Cell Center in the Technion’s Rappaport Faculty of Medicine.
 
The Power of microcarrier-free suspension culture
Traditional pluripotent stem cells are grown as adherent culture, with limited and expensive scalability. Accellta’s proprietary disruptive technology is a platform enabling novel solution for industrialization of stem cells and their derivatives based on high cell concentrations in dynamic culture without microcarriers. Therefore, enables cost-effective mass production of stem cells for clinical applications, regenerative medicine, cell banking and R&D applications. Accellta’s suspension culture can be applied as Maxells or as Single cell suspension on both embryonic and induced pluripotent stem cells and several progenitors or fully differentiated cells (e.g., MSCs, Neural progenitor cells, CMs). 


Maxells -
סינגלים 2Maxells, Accellta’s novel solution for industrialization of embryonic and induced pluripotent stem cell culturing, is based on dynamic culturing of stem cells in suspension without microcarriers. Maxells allows uniform cell growth and improved cell differentiation and delivers unprecedented scalability and quality. Maxells enables cost-effective mass production of stem cells for therapeutic purposes, banking and R&D applications. The technology is suitable for both stirred tank and Wave™ bioreactors.
 
Singles -
סינגלים 250"Singles" is a breakthrough technology that offers a simple and effective way to culture pluripotent stem cells as single-cells in suspension without microcarriers, providing enhanced uniformity and purity and also servs as a convenient platform for genetic manipulation of the cells.
 

 

 

Top Quality Cells and Methods
Accellta offers a variety of NIH-registered highly characterized ESC lines. In addition, we offer protocols for feeder-free and xeno-free culturing

Image
Contact Us

Contact Us

Address:

Malat Building, Technion City, Haifa, Israel 3200004

Tel: +972.4.8291070

Fax: +972.4.6299282

Mail: info@accellta.com

Please fill the required field.
Please fill the required field.

Atlas of Human Pluripotent Stem Cells

978 1 61779 548 0

Editors:

Michal Amit, Joseph Itskovitz-Eldor

Image

Accelerating stem cell technologies

Terms of use | Privacy Policy  |  © 2021

© 2021 Accellta. All Rights Reserved. Designed By Netron Israel Ltd.

Image

Accessibility Initiative Badge

Register / Login